October 10th, 2012
Sanofi is the only company to have developed a specific “Access to Medicines in Mental Health” program, to improve access to care for people suffering from a mental disorder in developing countries.
Mental disorders affect 450 million people worldwide (1). They are the second leading cause of morbidity and mortality in developing countries (2) where they have become a public health issue which is unfortunately too often ignored. In fact 80% of people with mental disorders in developing countries do not receive appropriate treatment (3)
The reasons are multiple, complex and intricate: lack of awareness among public health authorities, ignorance of the medical cause of symptoms that are often attributed to possession by spirits, stigmatisation of people with mental disorders, insufficient training of health professionals, poor accessibility of drugs …
Patients live on the fringe of society, being rejected, excluded and sometimes, in the most extreme c